Patents by Inventor Maria Kovalenko

Maria Kovalenko has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250026850
    Abstract: Provided herein are antibodies with binding specificity for CD39 and compositions comprising the antibodies, including pharmaceutical compositions, diagnostic compositions and kits. Also provided are methods of using anti-CD39 antibodies for therapeutic and diagnostic purposes.
    Type: Application
    Filed: September 24, 2024
    Publication date: January 23, 2025
    Inventors: Vanessa Soros, Maria Kovalenko, John Corbin, Courtney Beers, Paul Fredrick Widboom, Joseph Robert Warfield
  • Publication number: 20220372163
    Abstract: Provided herein are antibodies that selectively bind to CD39 and its isoforms and homologs, and compositions comprising the antibodies. Also provided are methods of using the antibodies, such as therapeutic and diagnostic methods.
    Type: Application
    Filed: May 30, 2022
    Publication date: November 24, 2022
    Applicant: TRISHULA THERAPEUTICS, INC.
    Inventors: Vanessa SOROS, Maria KOVALENKO, John CORBIN, Courtney BEERS, Paul Fredrick WIDBOOM, Joseph Robert WARFIELD
  • Publication number: 20220340680
    Abstract: Provided herein are antibodies with binding specificity for CD39 and compositions comprising the antibodies, including pharmaceutical compositions, diagnostic compositions and kits. Also provided are methods of using anti-CD39 antibodies for therapeutic and diagnostic purposes.
    Type: Application
    Filed: April 20, 2022
    Publication date: October 27, 2022
    Inventors: Vanessa Soros, Maria Kovalenko, John Corbin, Courtney Beers, Paul Fredrick Widboom, Joseph Robert Warfield
  • Patent number: 11345757
    Abstract: Provided herein are antibodies that selectively bind to CD39 and its isoforms and homologs, and compositions comprising the antibodies. Also provided are methods of using the antibodies, such as therapeutic and diagnostic methods.
    Type: Grant
    Filed: July 30, 2018
    Date of Patent: May 31, 2022
    Assignee: Trishula Therapeutics, Inc.
    Inventors: Vanessa Soros, Maria Kovalenko, John Corbin, Courtney Beers, Paul Fredrick Widboom, Joseph Robert Warfield
  • Publication number: 20210403593
    Abstract: Provided herein are antibodies that selectively bind to CD39 and its isoforms and homologs, and compositions comprising the antibodies. Also provided are methods of using the antibodies, such as therapeutic and diagnostic methods.
    Type: Application
    Filed: September 7, 2021
    Publication date: December 30, 2021
    Inventors: Vanessa Soros, Maria Kovalenko, John Corbin, Courtney Beers, Paul Fredrick Widboom, Joseph Robert Warfield
  • Publication number: 20210009708
    Abstract: Provided herein are antibodies that selectively bind to CD39 and its isoforms and homologs, and compositions comprising the antibodies. Also provided are methods of using the antibodies, such as therapeutic and diagnostic methods.
    Type: Application
    Filed: July 30, 2018
    Publication date: January 14, 2021
    Inventors: Vanessa SOROS, Maria KOVALENKO, John CORBIN, Courtney BEERS, Paul Fredrick WIDBOOM, Joseph Robert WARFIELD
  • Publication number: 20190062448
    Abstract: Provided herein are antibodies that selectively bind to CD39 and its isoforms and homologs, and compositions comprising the antibodies. Also provided are methods of using the antibodies, such as therapeutic and diagnostic methods.
    Type: Application
    Filed: July 30, 2018
    Publication date: February 28, 2019
    Inventors: Vanessa Soros, Maria Kovalenko, John Corbin, Courtney Beers, Paul Fredrick Widboom, Joseph Robert Warfield